The Quality Payment Program
This course will give a high-level overview of the Quality Payment Program (QPP). Historically, the provider payment system was flawed, focusing on volume vs. quality of care. This course will further define the QPP and its two-track pathways for Medicare-eligible participants, known as Qualifying Participants (QPs). The two QPP pathways, Merit-based Incentive Payment Systems (MIPS) and Alternative Payment Models (APMs) will be discussed, including enrollment stipulations and 2023 proposed payment changes. Lastly, this course will briefly discuss the COVID-19 implications affecting the QPP.
This course will give a high-level overview of the Quality Payment Program (QPP). Historically, the provider payment system was flawed, focusing on volume vs. quality of care. This course will further define the QPP and its two-track pathways for Medicare-eligible participants, known as Qualifying Participants (QPs). The two QPP pathways, Merit-based Incentive Payment Systems (MIPS) and Alternative Payment Models (APMs) will be discussed, including enrollment stipulations and 2023 proposed payment changes. Lastly, this course will briefly discuss the COVID-19 implications affecting the QPP.
Accreditation Council for Continuing Medical Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Relias LLC designates this enduring activity for a maximum of 0.50 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 0.50 Nursing Contact Hours after successfully completing this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.50 contact hours for participating in this course.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.50 contact hours for participating in this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Louisiana State Board of Medical Examiners
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
Michigan Board of Nursing
Michigan Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Mississippi State Board of Medical Licensure
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
New Mexico Medical Board
Physicians will receive 0.50 AMA PRA category 1 Credits™.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Ohio State Medical Board
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Tennessee Board Of Medical Examiners
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™
Recall the overarching concept of the QPP and the CMS 2023 proposed changes.
Identify how both the MIPS and APM QPP tracks work, the CMS 2023 proposed changes, and COVID-19 implications.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: QPP
Overview
QPP Inception
CMS 2023 QPP Changes
Knowledge Check
Key Takeaways
Section 3: MIPS
Overview
QPs and Eligibility
CMS 2023 MIPS Changes
Knowledge Check
Key Takeaways
Section 4: APMs
Overview
QPs and Eligibility
CMS 2023 APM Changes
Knowledge Check
Key Takeaways
Section 5: COVID-19 Implications
Overview
Covered COVID-19 Exemptions
Non-Covered COVID-19 Exemptions
Section 6: Conclusion
Course Summary
Course Contributor
Resources
References
Shalla is a subject matter expert (SME)/writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate (NE-BC). Shalla’s tenure spans over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, managed care/market access, nonprofit patient advocacy, and research. Her subject matter expertise is in rare, orphan, and complex diseases. Her sub-expertise is in immune-mediated diseases (rheumatology and immunology), genetics, neurology, hematology/oncology, several pediatric diseases, population/public health, and larger systemic healthcare affairs. Shalla is a published author with leading rare disease experts and a global speaker. She also sits on scientific, advocacy, and legislative advisory boards. She has led national advocacy and disease awareness campaigns, including speaking before congress, leading to the first-in-class rare disease biologic approval and investigative treatment protocols.
The target audience for this course is: Nurses; Physicians; in the following settings: All Healthcare Settings.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
